Skip to main content
Terug
Watch Compare

Cresco Labs Inc.

Datakwaliteit: 100%
CRLBF
OTC Manufacturing Chemicals
€ 0,93
▼ € 0,02 (-2,34%)
Marktkapitalisatie: 345,87 M
Prijs
€ 0,96
Marktkapitalisatie
345,87 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Generating 37,75 M in free cash flow
Capital efficient — spends only 5,36% of revenue on capex

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)-9,46%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-33,22%
Boven sectorgemiddelde (-53,34%)
ROIC-1,86%
Net Margin-20,65%
Op. Margin-4,27%

Veiligheid

Debt / Equity
1,26
Boven sectorgemiddelde (0,31)
Current Ratio2,59
Interest Coverage-0,67

Waardering

PE (TTM)
-2,55
Onder sectorgemiddelde (-1,47)
P/B Ratio1,02
EV/EBITDA34,54
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -2,6 -1,5
P/B 1,0 1,6
ROE % -33,2 -53,3
Net Margin % -20,7 -41,5
Rev Growth 5Y % — 1,8
D/E 1,3 0,3

Koersdoel Analisten

1 analist
Buy
Huidig
€ 0,93
+115.6%
Koersdoel
€ 2,00
€ 2,00
€ 2,00
€ 2,00
Vooruitzicht
Forward K/W -8,43
Forward WPA -€ 0,11
Omzet Sch. 651,84 M

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 0,11
-€ 0,11 – -€ 0,11
 651,84 M 1
FY2026 -€ 0,10
-€ 0,10 – -€ 0,10
 620,75 M 1

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 0,03 N/A —
Q32025 -€ 0,04 € 0,01 +120,4%
Q22025 -€ 0,04 -€ 0,02 +51,6%
Q12025 -€ 0,03 € 0,02 +187,0%

All Fundamental Metrics
Growth
Revenue Growth (1Y) -9,46% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 655,85 M Net Income (TTM) -135,41 M
ROE -33,22% ROA -10,61%
Gross Margin 49,49% Operating Margin -4,27%
Net Margin -20,65% Free Cash Flow (TTM) 37,75 M
ROIC -1,86% FCF Growth (3Y) N/A
Safety
Debt / Equity 1,26 Current Ratio 2,59
Interest Coverage -0,67 Asset Turnover 0,51
Working Capital 159,09 M Tangible Book Value -143,07 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2,55 Forward P/E N/A
P/B Ratio 1,02 P/S Ratio 0,53
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 34,54 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 10,92%
Market Cap 345,87 M Enterprise Value 715,85 M
Per Share
EPS (Diluted TTM) -0,38 Revenue / Share 1,82
FCF / Share 0,11 OCF / Share 0,20
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 5,36% FCF Conversion -27,88%
SBC-Adj. FCF 26,52 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024
Revenue 655,85 M 724,34 M
Net Income -135,41 M -74,44 M
EPS (Diluted) -0,38 -0,22
Gross Profit 324,57 M 364,45 M
Operating Income -27,99 M 107,29 M
EBITDA — —
R&D Expenses — —
SG&A Expenses 247,45 M 254,84 M
D&A 48,71 M 59,10 M
Interest Expense 41,75 M 37,93 M
Income Tax 44,62 M 49,87 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024
Total Assets 1,20 B 1,36 B
Total Liabilities 944,80 M 967,18 M
Shareholders' Equity 340,45 M 474,85 M
Total Debt 427,88 M 472,68 M
Cash & Equivalents 57,90 M 137,56 M
Current Assets 259,27 M 294,26 M
Current Liabilities 100,18 M 94,34 M